ViroCell Manufactured a GMP Lentiviral Vector for UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer Provided by Business Wire Apr 17, 2025, 6:00:00 AM ...

ViroCell Manufactured a GMP Lentiviral Vector for UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer. Share.

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform.. The deal will see AstraZeneca scoop up all ...

Lentiviral vector improves anemia and iron metabolism in new model for X-linked sideroblastic anemia. Jan. 22, 2025. No Comments. X-linked sideroblastic anemia (XLSA) is a rare genetic disorder caused ...

VIVEbiotech provides process development, manufacturing and analytical testing for leading biopharmaceutical companies engaged in gene therapy and cell therapy projects. With a specific focus on ...

Discover how innovative production and clarification products improve lentiviral vector generation. Share. The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, ...

Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, is introducing a new expanded service offering at its dedicated advanced therapies site in ...

Rentschler Biopharma launched an expanded service offering at its dedicated Advanced Therapy Medicinal Products (ATMP) site in Stevenage, U.K. The company introduced a new lentiviral vector ...

Charles River Laboratories International, Inc. and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and ...